Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of 12 citing Hodge: The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients.... (0.06 sec) 

A systematic review of the characteristics of randomised control trials featuring …


CW Lee, F Buckley, S Costello, S Kelly - Current Medical Research and Opinion®, 2008 - informahealthcare.com
Results: A total of 510 publications were identified. Of these, 181 studies had
a prostaglandin treatment arm. The median study duration was 12 weeks (IQR
4–13) and 78% of included trials had a duration of 3 months or less. The ...
Cited by 1 - Related articles - All 7 versions

New prostaglandin derivative for glaucoma treatment


E Perrino, C Uliva, C Lanzi, PD Soldato, E … - Bioorganic & Medicinal Chemistry Letters, 2009 - Elsevier
A hydrogen sulphide-releasing derivative of latanoprost acid (ACS 67) was
synthesized and tested in vivo to evaluate its activity on reduction of
intraocular pressure and tolerability. Glutathione (GSH) and cGMP content ...
Cited by 1 - Related articles - All 3 versions

Surveillance of Glaucoma Medical Therapy in a Glasgow Teaching Hospital: 26 Years …


MQ Rahman, DMI Montgomery, MN … - British Medical Journal, 2009 - bjo.bmj.com
Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ...
Related articles - All 3 versions

Outcome of Raised Intraocular Pressure in Uveitic Eyes with and without a Corticosteroid- …


A Sallam, HG Sheth, Z Habot-Wilner, S … - American Journal of Ophthalmology, 2009 - Elsevier
Of 891 patients with uveitis, 191 (275 eyes) had IOP elevation (21.4%). Of
these, 95 (34.5%) eyes had glaucoma. IOP elevation attributed to
corticosteroid-response (61.1%) was controlled more easily than that ...
Related articles - All 14 versions

Quantitative determination of a novel enantiomeric tropane analog,(-)-satropane, in …


J Fu, C Fang, YY Cui, LM Yang, L Zhu, XM … - Biomedical Chromatography, 2009 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Related articles - All 2 versions

Surveillance of Glaucoma Medical Therapy in


MQ Rahman, DMI Montgomery, MN … - bjo.bmj.com
Page 1. doi: 10.1136/bjo.2008.151522 published online July 23, 2009 Br J Ophthalmol
Mamun Q Rahman, Donald MI Montgomery and Marie-Noëlle Lazaridou ...
Related articles - All 2 versions

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma …


A Galanopoulos, I Goldberg, 2009 - pubmedcentral.nih.gov
Elevated intraocular pressure (IOP) is a significant risk factor for the
development and progression of glaucomatous optic neuropathy, but increasingly
we appreciate that non-pressure dependent factors, are key to our ...
Related articles - All 5 versions

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open …


O Eyawo, J Nachega, P Lefebvre, D Meyer, B …, 2009 - pubmedcentral.nih.gov
A meta-analysis was conducted of head-to-head randomized trials of prostaglandin
therapies. We included randomized trials assessing head-to-head evaluations of
prostaglandin analogues travoprost, latanoprost and bimatoprost in patients ...
Related articles - All 5 versions

Meta-analysis of Medical Intervention for Normal Tension Glaucoma


JW Cheng, JP Cai, RL Wei - Ophthalmology, 2009 - Elsevier
Pertinent publications were identified through systematic searches of PubMed,
EMBASE, and the Cochrane Controlled Trials Register. The patients had to be
diagnosed as having NTG. Methodological quality was assessed by the Delphi ...
Related articles - All 16 versions

[PDF] OPHTHALMICS, GLAUCOMA AGENTS


W PDLAC - uwacadweb.uwyo.edu
This publication is a result of the collaboration of the Goold Health Systems,
Inc. Clinical Workgroup and represents the opinion of these authors based on a
review of the literature available at the time it was written. It is ...
Related articles


Result Page: 

1

2

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google